bpc 157 protocol for injury BPC-157 Dosing (Common Protocols), 🔹 Oral / Subcutaneous, • 500 mcg daily, • Duration: 6 weeks, 🔹 Intramuscular / Peritendinous, • 1 mg daily, • Duration: 6 weeks, ⚠️ Note:, Not approved by FDA or Pack size:5 vials 30ml Hospira Brand Bacteriostatic OUR_PICK

bpc 157 protocol for injury BPC-157 Dosing (Common Protocols), 🔹 Oral / Subcutaneous, • 500 mcg daily, • Duration: 6 weeks, 🔹 Intramuscular / Peritendinous, • 1 mg daily, • Duration: 6 weeks, ⚠️ Note:, Not approved by FDA or Pack size:5 vials 30ml Hospira Brand Bacteriostatic OUR_PICK

30ml Hospira Brand Bacteriostatic Water for Injection

Whether that separation is always accurate depends on the study or model being referenced, which is one reason it’s useful to understand what each peptide is (and isn’t) known for

OUR_PICK

Pack size:5 vials

Deficiency can manifest as fatigue, weakness, cognitive changes, mood disturbance, numbness and tingling in the extremities, and—if prolonged—irreversible neurological damage